News - 2021
Check out the posts below to learn the latest updates on our progress
- December 21 2021EXUMA Biotech Completes Series B2 to Advance Novel Cell & Gene TherapiesPRNewswire
- September 22 2021EXUMA Biotech to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare ConferencePRNewswire
- August 2 2021Building Scientific Trust VirtuallyLife Science Leader
- April 9 2021Subcutaneous injection of total nucleated cells rapidly isolated following four-hour peripheral whole blood exposure to CD3-directed CAR-T lentiviruses with a synthetic driver results in robust CAR-T proliferation and anti-tumor immunityAACR Annual Meeting 2021
- February 16 2021EXUMA Biotech on NPR’s TechNation with Dr. Moira GunnTechNation Radio
- February 5 2021Economically Viable, Same-Day Autologous Cell TherapiesPharma's almanac
- January 11 2021EXUMA Biotech Announces Collaboration with Moffitt Cancer Center for the Development of a Rapid-Point-Of-Care SC CAR-T ProgramPRNewswire